Prazosin, pharmacokinetics and concentration effect
- PMID: 499317
- DOI: 10.1007/BF00562058
Prazosin, pharmacokinetics and concentration effect
Abstract
The pharmacokinetics and effects of prazosin have been studied after intravenous and oral dosing (1 mg) to 6 normal male volunteers. The mean terminal (beta) half-life was 2.9 h after intravenous and oral routes. Oral bioavailability was 56.9%. The effects of prazosin on blood pressure were more pronounced after intravenous than oral administration, and the hypotensive effect greater on erect blood pressure. There was a significant correlation (P less than 0.02) between the fall in blood pressure and the plasma drug concentration after intravenous prazosin.
Similar articles
-
Prazosin kinetics in essential hypertension.Clin Pharmacol Ther. 1980 Jul;28(1):6-11. doi: 10.1038/clpt.1980.123. Clin Pharmacol Ther. 1980. PMID: 7389255
-
Dose-dependent bioavailability of prazosin in beagle dogs.J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):613-7. doi: 10.1097/00005344-198307000-00016. J Cardiovasc Pharmacol. 1983. PMID: 6193359
-
Clinical pharmacokinetics of prazosin.Clin Pharmacokinet. 1980 Jul-Aug;5(4):365-76. doi: 10.2165/00003088-198005040-00004. Clin Pharmacokinet. 1980. PMID: 6994981 Review.
-
Prazosin kinetics in hypertension.Clin Pharmacol Ther. 1981 Oct;30(4):439-46. doi: 10.1038/clpt.1981.186. Clin Pharmacol Ther. 1981. PMID: 7285477
-
Clinical pharmacokinetics of prazosin--1985.Clin Pharmacokinet. 1985 Mar-Apr;10(2):144-54. doi: 10.2165/00003088-198510020-00002. Clin Pharmacokinet. 1985. PMID: 3888489 Review.
Cited by
-
A pharmacokinetic study of prazosin in patients with varying degrees of chronic renal failure.Eur J Clin Pharmacol. 1986;31(3):333-7. doi: 10.1007/BF00981133. Eur J Clin Pharmacol. 1986. PMID: 3792430
-
The effect of long-term administration of alpha 1-blocker prazosin on capillary density in cardiac and skeletal muscle.Pflugers Arch. 1989 Dec;415(3):355-60. doi: 10.1007/BF00370888. Pflugers Arch. 1989. PMID: 2622763
-
Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz.Naunyn Schmiedebergs Arch Pharmacol. 1986 Apr;332(4):370-5. doi: 10.1007/BF00500089. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3736681
-
Pharmacokinetic-pharmacodynamic relationships of alpha-adrenoceptor antagonists.Clin Pharmacokinet. 1989 Oct;17(4):264-74. doi: 10.2165/00003088-198917040-00004. Clin Pharmacokinet. 1989. PMID: 2574089 Review.
-
Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin.Eur J Clin Pharmacol. 1989;37(1):53-8. doi: 10.1007/BF00609425. Eur J Clin Pharmacol. 1989. PMID: 2591463 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources